secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2025-11-10T23:59:59+00:00
Accession:  0001193125-25-274193
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q3 revenue $29.4M (+3%); cuts FY 2025 revenue guidance to $115-120M
--------------------------------------------------------------------------------

- Net loss $17.8M vs $27.9M a year ago; non-GAAP net loss $12M vs $20.2M.
- Gross margin expanded to 39.4% (non-GAAP 39.9%) from 34.3% a year ago.
- FY 2025 revenue guidance reduced to $115-120M from prior $122-126M.
- Cash use improved to <$6M in Q3; total cash $182M at quarter end.
- Operating expenses declined 19% YoY to $27.4M; path to profitability focus.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000119312525274193/0001193125-25-274193-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000119312525274193/om-20251110.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-274193

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer